1.Traditional Chinese Medicine Combined with Chemotherapy in Prevention and Treatment of Recurrence and Metastasis of Locally Advanced Gastric Cancer After Radical Resection: A Meta-analysis
Yue WANG ; Weizhe ZHAO ; Xiaojie LI ; Mengdie NAN ; Meiwen XIE ; Peijin LI ; Li HOU
Cancer Research on Prevention and Treatment 2022;49(9):913-922
Objective To explore the efficacy and safety of traditional Chinese medicine(TCM) combined with chemotherapy in the prevention and treatment of postoperative recurrence and metastasis of locally advanced gastric cancer (LAGC) by meta-analysis. Moreover, we evaluated the efficacy of TCM on the quality of life, immune indexes, and toxic and side effects during adjuvant chemotherapy. Methods The CNKI, Wanfang, PubMed, and other databases were searched by computer. Randomized controlled trials (RCTs) were searched. After literature screening and data extraction, Review Manager 5.3 software provided by Cochrane was used for meta-analysis. Results A total of 18 RCTs were included. Compared with chemotherapy alone, TCM combined with chemotherapy could improve the KPS score and CD3+ and CD4+/CD8+ index levels. The incidence rates of postoperative leucopenia, hemoglobin reduction, thrombocytopenia, nausea and vomiting, diarrhea, and neurotoxicity were reduced. In terms of postoperative QLQ-C30 score, abnormal liver function, and abnormal renal function, the incidence of TCM combined chemotherapy was similar to that of chemotherapy alone, with no statistical difference. Compared with chemotherapy alone, TCM combined chemotherapy could reduce the 1-, 2-, 3-, and 5-year cumulative recurrence and metastasis rates and prolong the disease-free survival time. Conclusion Compared with chemotherapy alone in adjuvant chemotherapy, TCM combined chemotherapy could improve the immune level and KPS score of LACC patients after surgery, reduce the incidence of adverse reactions, as well as reduce the recurrence and metastasis rate of LAGC after surgery and DFS could be improved.
2.Investigation on anti-tumor mechanism of tea polyphenol and epigallocatechin gallate based on immunity regulation
Guangda LI ; Jing WANG ; Jing XU ; Meiwen XIE ; Yibin ZHOU ; Li HOU
China Pharmacy 2022;33(24):3067-3072
Tea polyphenol (TP) is the main active constituent in tea, and epigallocatechin gallate (EGCG) is the main active constituent of TP that plays a biological role. Both of them can be used as immunomodulators in the treatment of tumor. In this paper, the anti-tumor mechanism of TP and EGCG was summarized from two aspects: enhancing immune effect and improving immune escape. The results showed that TP and EGCG could not only enhance the anti-tumor immune effect by promoting the activity of immune cells and the secretion of cytokines, but also improve tumor immune escape by regulating immunosuppressive cells, immune checkpoints, cytokines, immunomodulatory enzymes and JAK/STAT pathway, which has great potential in tumor immunotherapy.